华仁药业股东华仁世纪集团拟减持不超3%公司股份

Group 1 - The core point of the article is that Huaren Pharmaceutical (300110) announced a share reduction plan by its major shareholder, Huaren Century Group, intending to reduce up to 3% of the company's total shares within three months through centralized bidding and block trading [1] - As of the announcement date, Huaren Century Group holds 81.54 million shares, accounting for 6.9% of the total share capital of the company [1] - The reason for the planned reduction is stated to be the operational needs of Huaren Century Group [1]